Nearly 30 yr ago, Stewart Cameron caused a minor revolution by pointing out that simple quantitation of proteinuria was much better at predicting outcome than histopathological diagnosis-then the gold standard prognostic marker. 1 We now know that severe proteinuria does not simply reflect glomerular injury but is itself harmful. 2 Reabsorption of large amounts of protein from the glomerular filtrate induces stress responses in proximal tubular epithelial cells that result in lysosomal instability and can even initiate epithelial-mesenchymal transition. 3 Epithelial cells synthesize chemokines, cytokines, and complement components that recruit inflammatory cells and lymphocytes into the interstitium causing progressive fibrosis. A fascinating paper by Macconi et al. from Ariela Benigni's group in the current issue of JASN 4 adds another layer of complexity by showing that albumin reabsorbed from proximal tubules induces the generation of albumin-specific, IFN-␥ secreting, CD8 T cells that may contribute to progressive renal injury.
Before discussing the results in detail, it is important to consider how proteins reabsorbed by the proximal tubule are presented to T cells. The interstitium of normal kidneys contain numerous resident monocytic myelocytes, traditionally believed to be macrophages because they express relevant markers such as F4/80 in mice and CD68 in man. 5 It is now known they also express dendritic cell markers and can indeed present antigen-one of the defining features of renal dendritic cells with broadly similar characteristics to dendritic cells in other tissues. [5] [6] [7] [8] [9] [10] Studies in mice with fluorescently labeled dendritic cells show essentially all resident myeloid cells are dendritic, reveal their intimate connection with renal tubules through long processes kissing the epithelial cells, and thus are ideally positioned to sample reabsorbed antigens or receive activation signals from them. 6, 7 Consequently, renal dendritic cells are the likely sentinals that sample renal antigens and present them to T cells. The endocytosed antigen is processed in one of two ways: either in endocytic compartments to create peptides that are loaded on to MHC class II molecules that present to CD4 ϩ T helper and T regulatory cells, 11 or, alternatively, they are processed by a different pathway involving proteosomal degradation that loads MHC class I molecules for presentation to CD8 ϩ T cells. 12 This latter pathway is known as "cross-presentation" and is the exclusive focus of the work considered here.
Macconi et al. investigate how reabsorbed albumin interacts with the immune system. 4 First they show that albumin endocytosed by rat proximal tubular cells in vitro is digested to a discrete set of peptides that are released into the supernatants of cultured cells-the predominant peptide being the aminoterminus fragment, albumin 1 to 24. Next, they demonstrate that albumin 1 to 24 is endocytosed by rat dendritic cells and digested by a proteasome-dependent pathway to 8-to 10-mer peptides that are loaded onto MHC class I molecules and presented to CD8 ϩ T cells. The first encounter between albumin 1-to 24-pulsed renal dendritic cells primes naive CD8
ϩ T cells, so that when exposed a second time, CD8 cells become activated and secrete IFN-␥. The authors then went on to prove this was not an in vitro artifact with an experimental tour-deforce using T cells and dendritic cells harvested from kidneys and draining lymph nodes of rats made proteinuric by 5/6 nephrectomy. They demonstrate 4 wk after nephrectomy that CD8 T cells purified from renal lymph nodes produce IFN-␥ when incubated with renal dendritic cells pulsed with albumin 1 to 24 -suggesting they were educated in vivo during the course of the disease. This suggestion was confirmed by further experiments showing that CD8 ϩ T cells harvested in the same way 1 wk after nephrectomy do not respond when first cultured with albumin-pulsed dendritic cells but behave like the naive CD8 ϩ T cells in the in vitro studies; that is, they need priming to produce an albumin 1-to 24-specific IFN-␥ response. Similarly, in vivo treatment with the proteosome inhibitor, bortezomib, which prevents MHC class I loading with antigen, prevents CD8 education in vivo. Taken together, these results provide a compelling case that rats develop IFN-␥-secreting CD8 ϩ (presumptively cytotoxic) T cell responses to albumin after 5/6 nephrectomy.
The results from the Begnini group present an interesting contrast with a paper published earlier this year, from Christian Kurts' group. 13 The approach was very similar except the latter experiments were performed in normal mice and the antigen examined, ovalbumin, was small enough to be freely filtered by the glomerulus. As expected, administered ovalbumin concentrates in the kidney, principally in proximal tubules, and transfers to dendritic cells in the kidney and the renal lymph nodes. Here it is cross-presented to CD8 ϩ T cells that react by proliferating when pulsed with ovalbumin. However, the outcome contrasted with the Macconi studies in that the responding T cells did not produce IFN-␥ or become cytotoxic but instead became apoptotic.
Accordingly, both studies demonstrate that filtered antigen concentrated and reabsorbed by the proximal tubular epithelium is cross-presented to CD8 ϩ T cells by renal dendritic cells or dendritic cells in the draining lymph node. However, both studies suggest the T cell response depends on context. Crosspresentation by dendritic cells from normal kidneys reinforces immunological tolerance to the filtered antigen whereas crosspresentation by dendritic cells from a proteinuric kidney results in an active immune response. This idea is consistent with data on cross-presentation in other contexts: these other contexts show that for cross-presentation to result in active immunity, the presenting dendritic cells must be exposed to endogenous signals released from dead or damaged cells-so called "damage-associated molecular patterns" (DAMPs). 14 Much more needs to be known before the role of albuminspecific T cells can be clinically assessed in chronic kidney disease. Obviously the critical question is whether these albuminspecific, IFN-␥-producing CD8 ϩ T cells cause injury-an issue not addressed in the paper presented here. For example, do CD8 ϩ T cells kill albumin-pulsed renal epithelial cells? They also raise issues about the role of the epithelial cells themselves-is processing to albumin 1 to 24 essential for the response of dendritic cells or is intact albumin equally good at generating CD8 primed T cells? Do the epithelial cells express the DAMPs, and if so, what are the critical molecules and which dendritic cell receptors do they ligate? Answers to these and other questions are bound to be forthcoming very shortly.
In conclusion, the demonstration of a highway for rapidly concentrating small protein molecules and delivering them directly into the renal interstitium or lymph nodes raises the wealth of exciting therapeutic possibilities for understanding and managing progressive renal injury.
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